Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
April 06, 2026) Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich ...
Scientists are uncovering a surprising connection between autism and ADHD that goes deeper than labels. Instead of diagnoses, it’s the severity of autism-like traits that seems to shape how the brain ...
BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced an oral presentation at the United States and Canadian Academy of Pathology (USCAP) 115th Annual ...
Scientists mapped the maternal–fetal interface revealing new cell types, genetic links, and mechanisms behind pregnancy complications.
A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company UP Oncolytics showed encouraging preclinical results in two studies presented at the American ...
In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and ...
Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development. By combining molecular targeting with controlled radiation delivery, these therapies introduce a ...
Immunity is orchestrated by two responses referred to as the innate and adaptive immune systems. Each system works to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results